{"transactions":[{"id":802967,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-04-22T16:21:15.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027."}],"balance_after":2150,"derivative":{"exercise_price":2.36,"exercise_date":"2027-04-20","expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001104659-26-046846","document":"tm2612397-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465926046846/tm2612397-8_4seq1.xml","form_type":"4"}},{"id":1306800,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants for Common Stock","published_at":"2025-01-08T16:31:59.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":24631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock."}],"balance_after":24631,"derivative":{"exercise_price":0.9,"exercise_date":"2025-01-07","expiration_date":"2030-01-07","underlying":"Common Stock","underlying_shares":24631},"source":{"system":"sec-edgar","filing":"0001104659-25-002053","document":"tm252665-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465925002053/tm252665-5_4seq1.xml","form_type":"4"}},{"id":1306799,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T16:31:59.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":24631,"price":1.015,"value":25000.465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc."}],"balance_after":137183,"source":{"system":"sec-edgar","filing":"0001104659-25-002053","document":"tm252665-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465925002053/tm252665-5_4seq1.xml","form_type":"4"}},{"id":1475589,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-18T16:14:27.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 17, 2025."}],"balance_after":12000,"derivative":{"exercise_price":2.38,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-24-072812","document":"tm2417510-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465924072812/tm2417510-4_4seq1.xml","form_type":"4"}},{"id":1674321,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants for Common Stock","published_at":"2024-01-22T06:15:17.000Z","date":"2024-01-19","kind":"exercise","planned":false,"acquired":false,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.55,"exercise_date":"2023-01-27","expiration_date":"2024-01-27","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001104659-24-005357","document":"tm243721-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465924005357/tm243721-1_4seq1.xml","form_type":"4"}},{"id":1674320,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-22T06:15:17.000Z","date":"2024-01-19","kind":"exercise","planned":false,"acquired":true,"shares":19737,"price":3.55,"value":70066.35,"ownership":{"direct":true},"balance_after":112552,"source":{"system":"sec-edgar","filing":"0001104659-24-005357","document":"tm243721-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465924005357/tm243721-1_4seq1.xml","form_type":"4"}},{"id":1852581,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-16T17:45:32.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 15, 2024."}],"balance_after":10000,"derivative":{"exercise_price":2.75,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-072369","document":"tm2319012-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465923072369/tm2319012-2_4seq1.xml","form_type":"4"}},{"id":2200367,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants for Common Stock","published_at":"2022-07-29T17:02:44.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19737,"derivative":{"exercise_price":3.55,"exercise_date":"2023-01-27","expiration_date":"2028-01-27","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001104659-22-084317","document":"tm2222169-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465922084317/tm2222169-3_4seq1.xml","form_type":"4"}},{"id":2200366,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants for Common Stock","published_at":"2022-07-29T17:02:44.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19737,"derivative":{"exercise_price":3.55,"exercise_date":"2023-01-27","expiration_date":"2024-01-27","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001104659-22-084317","document":"tm2222169-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465922084317/tm2222169-3_4seq1.xml","form_type":"4"}},{"id":2200365,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-29T17:02:44.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":19737,"price":3.8,"value":75000.6,"ownership":{"direct":true},"balance_after":92815,"source":{"system":"sec-edgar","filing":"0001104659-22-084317","document":"tm2222169-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465922084317/tm2222169-3_4seq1.xml","form_type":"4"}},{"id":2495692,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:06:28.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":5161,"price":4.84,"value":24979.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.73 to $4.86 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price."}],"balance_after":73078,"source":{"system":"sec-edgar","filing":"0001104659-21-143551","document":"tm2133903-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465921143551/tm2133903-1_4seq1.xml","form_type":"4"}},{"id":2573413,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T16:16:31.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":12500,"price":6,"value":75000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Acurx Pharmaceuticals, Inc. (the \"Issuer\") purchased by the reporting person in connection with the Issuer's initial public offering, which closed on June 29, 2021. Due to an unintentional oversight, the transaction reported on this Form 4 was not previously filed on a Form 4 in a timely manner and was omitted from one Form 4 that was subsequently filed. The 12,500 shares of common stock of the Issuer were purchased at the initial public offering price of $6.00 per share."}],"balance_after":67917,"source":{"system":"sec-edgar","filing":"0001104659-21-114674","document":"tm2127171d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465921114674/tm2127171d1_4.xml","form_type":"4"}},{"id":2641595,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51651,"kind":"person","name":"Sailer Carl","position":1,"cik":"0001854182","reported_name":"Sailer Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-06T16:13:26.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024."}],"balance_after":50000,"derivative":{"exercise_price":6.18,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-089414","document":"tm2121302d4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854182/000110465921089414/tm2121302d4_4seq1.xml","form_type":"4"}}]}